TMC
SGMO

Trellus Management Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Trellus Management Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-30,000
Closed -$286K – 75
2019
Q1 		$286K Buy
+30,000
New +$306K 0.54% 46
2014
Q3 		– Sell
-25,000
Closed -$382K – 131
2014
Q2 		$382K Buy
25,000
+12,900
+107% +$186K 0.32% 78
2014
Q1 		$219K Buy
+12,100
New +$233K 0.2% 100
2013
Q4 		– Sell
-30,400
Closed -$319K – 113
2013
Q3 		$319K Sell
30,400
-20,000
-40% -$199K 0.4% 75
2013
Q2 		$394K Buy
+50,400
New +$440K 0.5% 62

Other funds holding SGMO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Trellus Management Company's SGMO Position: Q2 2019 in Review

Trellus Management Company sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 30,000 shares — an estimated $286K sold.

Trellus Management Company first reported a position in SGMO in Q2 2013 and held it in 5 quarters. The position peaked at $394K in Q2 2013. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • Trellus Management Company reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • Trellus Management Company sold 30,000 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $286K.
  • Trellus Management Company first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 5 quarters.
  • Trellus Management Company's SANGAMO THERAPEUTICS INC position peaked at $394K in Q2 2013.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on Trellus Management Company's 13F filing for Q2 2019, filed 31 Jul 2019.